Biomarin Pharmaceutical (BMRN) stock forecast for 2022 – 2027

Are you interested in BioMarin Pharmaceutical Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BMRN stock price in 2022-2027. Is BMRN a good long term stock? When should I take profit in Biomarin Pharmaceutical stock? Buy or sell stock? Will BMRN stock price go up? What are analysts’ forecasts for BMRN stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. BMRN stock returns are also predicted based on historical data.

According to our research, BMRN stock is a bad long-term investment. BMRN share price has been in a bear cycle for the past year. BioMarin Pharmaceutical Inc. stock trend is bearish.

Biomarin Pharmaceutical company info

Industry Biotechnology
Address 770 Lindaro Street, San Rafael, CA, 94901, United States
Website https://www.biomarin.com

Forecasting

52 Week High: 90.0738 USD
52 Week Low: 84.5223 USD
1 Year Forecast: 85.1066 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 16.26B
52 Week Change: 5.213%
52 Week High: 92.17 USD
52 Week Low: 71.59 USD
Beta: 0.879454
50 Day Moving Average: 86.72
90 Day Moving Average: 85.975
200 Day Moving Average: 81.3
Resistance Level: 91.9403
Pivot Point: 88.8093
Support Level: 83.741
Enterprise Value: 16,346,255,360
Forward P/E: 183.32
Forward EPS: 0.47
Profit Margin: 0.86%
Shares Outstanding: 183,592,992
EBITDA: 284.22
Held Percent Institutions: 97.41%
PEG Ratio (5Y): -7.53
Trailing EPS: 0.04

Biomarin Pharmaceutical stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Biomarin Pharmaceutical Stock Forecast for 2022

March 2022 87.87 83.3 -5.2%
April 2022 86.7 85.26 -1.66%
May 2022 88.74 89.76 1.15%
June 2022 86.24 90.9 5.4%
July 2022 88.2 89.18 1.11%
August 2022 92.82 86 -7.35%
September 2022 86.86 85 -2.14%
October 2022 82.32 83 0.83%
November 2022 84.66 82.32 -2.76%
December 2022 84.84 86 1.37%

Biomarin Pharmaceutical Stock Forecast for 2023

January 2023 84.28 84 -0.33%
February 2023 84.84 85.85 1.19%
March 2023 83.3 82.82 -0.58%
April 2023 83.64 82.32 -1.58%
May 2023 84 84.15 0.18%
June 2023 84.15 88.74 5.45%
July 2023 86.13 88.11 2.3%
August 2023 87.12 83.83 -3.78%
September 2023 84.66 82.82 -2.17%
October 2023 80.36 79.2 -1.44%
November 2023 78.4 80.19 2.28%
December 2023 80.19 82.17 2.47%

Biomarin Pharmaceutical Stock Forecast for 2024

January 2024 84.66 82.62 -2.41%
February 2024 79.38 82.82 4.33%
March 2024 80.36 81.6 1.54%
April 2024 81.6 81.18 -0.51%
May 2024 80.36 81.34 1.22%
June 2024 81.34 84 3.27%
July 2024 84.15 87.72 4.24%
August 2024 86 81.81 -4.87%
September 2024 79.38 80.8 1.79%
October 2024 80.58 77.22 -4.17%
November 2024 76.44 80.58 5.42%
December 2024 79.79 79.38 -0.51%

Biomarin Pharmaceutical Stock Forecast for 2025

January 2025 80.19 79 -1.48%
February 2025 80.58 80.8 0.27%
March 2025 78.4 77 -1.79%
April 2025 77.77 77.42 -0.45%
May 2025 78.21 80.8 3.31%
June 2025 81.6 83.64 2.5%
July 2025 82.82 81.34 -1.79%
August 2025 82.17 79.56 -3.18%
September 2025 77.22 75.46 -2.28%
October 2025 77 75 -2.6%
November 2025 76.5 76.76 0.34%
December 2025 77.52 78.78 1.63%

Biomarin Pharmaceutical Stock Forecast for 2026

January 2026 79.56 74.48 -6.39%
February 2026 75.24 75.46 0.29%
March 2026 78.78 76.5 -2.89%
April 2026 75.75 76.23 0.63%
May 2026 78.54 77.22 -1.68%
June 2026 79.56 78.4 -1.46%
July 2026 79.2 79.38 0.23%
August 2026 79.38 76 -4.26%
September 2026 76 75.75 -0.33%
October 2026 73.5 73 -0.68%
November 2026 72.27 75.48 4.44%
December 2026 74.74 76.76 2.7%

Biomarin Pharmaceutical Stock Forecast for 2027

January 2027 77.52 73.26 -5.5%